I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer
A single-arm, two-stage, open-label, phase 2 study investigating the safety and efficacy of intravesical gemcitabine/docetaxel for bacillus Calmette-Guerin (BCG)-nave patients with non-muscle invasive bladder cancer (NMIBC). All participants will receive an induction course of gemcitabine/docetaxel instillations followed by maintenance instillations if initial efficacy is seen.
follicle stimulating hormone
oophorectomy
recurrent tumor
carcinoma in situ
carcinoma
- 0 views
- 19 Feb, 2024